Renovis Surgical Technologies attracted 22 investors to a recent funding round that hit the hoped-for $5.3 million mark, according to an SEC filing.
The equity funding round kicked off in April, on the heels of another funding round that drummed up $3.5 million in cash for the Redlands, Calif.-based medical device maker.
Renovis develops surgical orthopedic devices and has several FDA-cleared surgical instruments, including its recently cleared A200 knee replacement system.
